Table 7.
Study | Species | Exp. | Region | Genes | Mark(s) | Findings |
---|---|---|---|---|---|---|
(Govorko et al., 2012) | Sprague Dawley rats | Liquid alcohol diet | Hypo. | Set7, G9A, Setdb1 | H3K4me2, H3K4me3, H3K9me2 | - Decreased H3K4me2, H3K4me3, and Set7 in the arcuate area of the hypothalamus |
- Increased H3K9me2, G9A and Setdb1 in the arcuate area of the hypothalamus | ||||||
(Bekdash et al., 2013) | Sprague Dawley rats | Liquid alcohol diet | Hypo. | Set7/9A, G9A, Setdb1 | H3K4me2/3, H3K9me2, H3K9Ac | - Choline administration prevents decreases in H3K4me2/3 and Set7/9 |
- Choline administration prevents increases in H3K9me2 and G9A and Setdb1 | ||||||
(Subbanna et al., 2013) | C57BL/6 | i.p. 2.5 g/kg | Hipp. NeoCtx | G9A, CC3, and Tau | H3K9me2, H3K27me3 | - Increased G9A expression, H3K9me2 and H3K27me3, and G9A activity in neocortex and hippocampus |
- Treatment with G9A inhibitor prevents increases in Tau and CC3 protein | ||||||
(Subbanna et al., 2014) | C57BL/6 | i.p. 1 g/kg | Hipp. NeoCtx | G9A, CC3, and Tau | H3K9me2, H3K27me3 | - Increased G9A, expression H3K9me2 and H3K27me3 and G9A activity in neocortex and hippocampus |
- Treatment with G9A inhibitor prevents increases in Tau and CC3 protein | ||||||
(Subbanna et al., 2015) | C57BL/6 | i.p 2.5 g/kg | Hipp. NeoCtx | Cb1 | H3K9me2 | - Decreased H3K9me2 associated with Cb1 promoter |
(Veazey et al., 2015) | C57BL/6 | i.p 2.9 g/kg | Cortex | 24 genes | H3K4me3, H3K27me3, H3K9me2 | - Broadly, H3K27me3 was decreased and H3K9me2 was increased associated with genes in animals with craniofacial deformities |
Abbreviations, Exp = exposure, i.p. = intraperitoneal, Hyp = hypothalamus, hipp = hippocampus, NeoCtx = Neocortex.